Get a Sample Research Report @ https://www.databridgemarketresearch.com/reports/global-achalasia-cardia-market
Key Growth Drivers:
Moreover, growing awareness for disease symptoms and pipeline drugs also boost the market growth. Technological advancements for disease diagnosis and rising healthcare expenditure act as an opportunity for market growth. But, delayed diagnosis, post-surgical complications and strict regulatory framework may hamper the global achalasia cardia market.
Achalasia cardia is one of the neurodegenerative disorders of the esophagus, which has been reported to affect peristaltic movement and results in impairment of relaxation of the lower oesophageal sphincter. The achalasia cardia pathogenesis is still unknown; however, several studies conducted revealed an autoimmune disorder that triggered the degeneration of myenteric neurons. The high-resolution oesophageal topography and endoscopy can diagnose achalasia cardia. High-resolution manometry is also used for the diagnosis of achalasia cardia. Achalasia cardia is of three types based on the manometric patterns: type I, classic represented by the minimal contractility, type II with panesophageal pressurization, and type III characterized by the spastic distal esophageal contractions. Achalasia cardia can be managed by applying botulinum toxin, pneumatic balloon dilation, laparoscopic Heller myotomy, among others.
The report outlines the involvement of key players, including:
The major players covered in the achalasia cardia market are Allergan, Ipsen Pharma, Merz Pharma, Medytox, Inc., Lanzhou Institute of Biological Products. Co.Ltd., Revance Therapeutics, Inc., Boston Scientific, Cook, Cardinal Health, Medical Devices Business Services, Inc., Hospiinz, Surgical Innovations, Evolus, Inc., Medorah Meditek Pvt. Ltd., STERIS, PENTAX Medical, XION GmbH, Aohua Endoscopy Co., Ltd., Laborie, Inc., Sumitomo Bakelite Co., Ltd., Medtronic, PENTAX Medical among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Key Market Segmentation
- On the basis of disease type, the achalasia cardia market is segmented into Type A, Type B, Type C and Type E.
- On the basis of diagnosis, the achalasia cardia market is segmented into physical examination, skin biopsy, biochemical testing, genetic testing.
- On the basis of treatment, the achalasia cardia market is segmented into miglustat, physical therapy and others.
- On the basis of end-users, the achalasia cardia market is segmented into clinics, hospitals, diagnostic centers, and others.
- On the basis of distribution channel, the achalasia cardia market is segmented into direct tenders, hospital pharmacy, retail pharmacy, online pharmacy and others.
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-achalasia-cardia-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-hashimotos-thyroiditis-drug-market
https://www.databridgemarketresearch.com/reports/global-house-dust-mite-allergy-treatment-market
https://www.databridgemarketresearch.com/reports/global-cell-separation-technology-market
https://www.databridgemarketresearch.com/reports/global-lymphangioleiomyomatosis-treatment-market
https://www.databridgemarketresearch.com/reports/global-skin-replacements-and-substitutes-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
